These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Increased levels of nm23 H1/nucleoside diphosphate kinase A mRNA associated with adenocarcinoma of the prostate. Jensen SL; Wood DP; Banks ER; Veron M; Lascu I; McRoberts JW; Rangnekar VM World J Urol; 1996; 14 Suppl 1():S21-5. PubMed ID: 8738406 [TBL] [Abstract][Full Text] [Related]
4. Multiple mechanisms underlie metastasis suppressor function of NM23-H1 in melanoma. Novak M; Jarrett SG; McCorkle JR; Mellon I; Kaetzel DM Naunyn Schmiedebergs Arch Pharmacol; 2011 Oct; 384(4-5):433-8. PubMed ID: 21448569 [TBL] [Abstract][Full Text] [Related]
5. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds. Ouatas T; Halverson D; Steeg PS Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169 [TBL] [Abstract][Full Text] [Related]
6. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer. Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904 [TBL] [Abstract][Full Text] [Related]
7. Association of nm23 protein levels in human prostates with proliferating cell nuclear antigen expression at autopsy. Igawa M; Urakami S; Shiina H; Ishibe T; Usui T; Chodak GW Eur Urol; 1996; 30(3):383-7. PubMed ID: 8931974 [TBL] [Abstract][Full Text] [Related]
8. Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity. Zhang Q; McCorkle JR; Novak M; Yang M; Kaetzel DM Int J Cancer; 2011 Jan; 128(1):40-50. PubMed ID: 20209495 [TBL] [Abstract][Full Text] [Related]
9. A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction. Carotenuto M; de Antonellis P; Chiarolla CM; Attanasio C; Damiani V; Boffa I; Aiese N; Pedone E; Accordi B; Basso G; Navas L; Imbimbo C; Zollo M Naunyn Schmiedebergs Arch Pharmacol; 2015 Feb; 388(2):257-69. PubMed ID: 25138575 [TBL] [Abstract][Full Text] [Related]
10. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients. Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493 [TBL] [Abstract][Full Text] [Related]
11. [Comparative proteomics study on human high-metastatic large cell lung cancer cell lines before and after transfecting with nm23-H1 gene]. Gao L; Zhu W; Li L; Hou M; Ma L; Zhao Y; Zhou Q Zhongguo Fei Ai Za Zhi; 2010 Oct; 13(10):928-32. PubMed ID: 20959063 [TBL] [Abstract][Full Text] [Related]
13. Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters. Nakopoulou LL; Tsitsimelis D; Lazaris AC; Tzonou A; Gakiopoulou H; Dicoglou CC; Davaris PS Cancer Detect Prev; 1999; 23(4):297-308. PubMed ID: 10403901 [TBL] [Abstract][Full Text] [Related]
14. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma. Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640 [TBL] [Abstract][Full Text] [Related]
15. Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis. Marino N; Marshall JC; Collins JW; Zhou M; Qian Y; Veenstra T; Steeg PS Cancer Res; 2013 Oct; 73(19):5949-62. PubMed ID: 23940300 [TBL] [Abstract][Full Text] [Related]
16. [Effect of Nm23-H1 Nuclear Localization on Proliferation of Human Lung Adenocarcinoma Cell Line A549]. Sheng Y; Xiong Y; Xu M; Kuang X; Wang D; Yang X Zhongguo Fei Ai Za Zhi; 2017 Apr; 20(4):226-232. PubMed ID: 28442010 [TBL] [Abstract][Full Text] [Related]
17. Nm23-H1 inhibits lung cancer bone-specific metastasis by upregulating miR-660-5p targeted SMARCA5. Ai C; Ma G; Deng Y; Zheng Q; Gen Y; Li W; Li Y; Zu L; Zhou Q Thorac Cancer; 2020 Mar; 11(3):640-650. PubMed ID: 32022430 [TBL] [Abstract][Full Text] [Related]
18. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434 [TBL] [Abstract][Full Text] [Related]
19. Identification of nm23-H1 as a metastatic suppressor and prognostic factor in nasopharyngeal carcinoma by proteomic analysis. Li X; Hu R; Qu J; He Q; Chen Y; Li J; Ye X; Xiang Y; Yi H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):17-26. PubMed ID: 22349375 [TBL] [Abstract][Full Text] [Related]
20. Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer. Yamaguchi A; Ding K; Maehara M; Goi T; Nakagawara G Oncology; 1998; 55(4):357-62. PubMed ID: 9663428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]